Suppr超能文献

第七版美国癌症联合委员会(AJCC)胃癌TNM分期系统的评估:队列研究的荟萃分析

Evaluation of the seventh AJCC TNM staging system for gastric cancer: a meta-analysis of cohort studies.

作者信息

Zhang Jizhun, Zhou Yangbing, Jiang Kewei, Shen Zhanlong, Ye Yingjiang, Wang Shan

机构信息

Department of Gastroenterological Surgery, People's Hospital, Peking University, Beijing, 100044, People's Republic of China.

出版信息

Tumour Biol. 2014 Sep;35(9):8525-32. doi: 10.1007/s13277-014-1848-6. Epub 2014 Apr 3.

Abstract

The AJCC seventh edition TNM classification for gastric cancer was released in 2010 and included major revision. Large-volume gastric cancer centers have evaluated the prognostic significance of the new system and obtained paradoxical results. The authors performed a meta-analysis of these studies to evaluate the new classification. Fifteen eligible studies with 38,972 patients were included in the analysis. Hazard ratios (HRs) and associated 95 % confidence intervals were extracted from identified studies. The primary outcome was overall survival. The HRs for the seventh edition T classification and N classification were found to increase steadily and reasonably. The cumulative survival rates of the seventh edition subgroups of T classifications demonstrated obvious differences; meanwhile, the differences between subgroups of N classifications including N3a and N3b categories were also significant. The 5-year survival rates according to the seventh edition TNM staging system were 94.71 % (stage IA), 88.72 % (stage IB), 80.45 % (stage IIA), 67.24 % (stage IIB), 53.68 % (stage IIIA), 37.56 % (stage IIIB), and 21.26 % (stage IIIC), respectively. The results of this study indicate that the seventh edition of the TNM classification was considered valid, although further evaluation was needed for N3a and N3b categories.

摘要

美国癌症联合委员会(AJCC)胃癌TNM分期第七版于2010年发布,包含重大修订。大型胃癌中心已对新系统的预后意义进行了评估,但结果自相矛盾。作者对这些研究进行了荟萃分析以评估新分类。分析纳入了15项符合条件的研究,共38972例患者。从纳入的研究中提取风险比(HRs)及相关的95%置信区间。主要结局为总生存期。发现第七版T分期和N分期的HRs稳步且合理地升高。第七版T分期亚组的累积生存率显示出明显差异;同时,包括N3a和N3b类别的N分期亚组之间的差异也很显著。根据第七版TNM分期系统的5年生存率分别为94.71%(IA期)、88.72%(IB期)、80.45%(IIA期)、67.24%(IIB期)、53.68%(IIIA期)、37.56%(IIIB期)和21.26%(IIIC期)。本研究结果表明,TNM分期第七版被认为是有效的,尽管对于N3a和N3b类别还需要进一步评估。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验